CSO
HTD Biosystems Inc
Livermore, California
Dr. Mitra Mosharraf is Chief Scientific Officer at HTD Biosystems and Co-Founder & CEO of Engimata Inc., bringing over 20 years of experience in biologics, nanomedicine, and advanced drug delivery systems. She has led innovation in lipid-based therapeutics, vaccine formulations, and complex biologics manufacturing, contributing to multiple patents during her tenure at Pharmacia/Pfizer. Dr. Mosharraf also focuses on the integration of AI/ML in pharmaceutical development, addressing challenges in implementation, regulatory requirements, and future applications. As 2025 Chair of the AAPS Nanotechnology Community, she champions industry collaboration on emerging technologies, manufacturing, and quality standards. She holds a Ph.D. in Pharmaceutical Sciences and an Executive MBA from the MIT Sloan School of Management.
Disclosure information not submitted.
Strategies for Manufacturing and Analysis of Lipid-Based Nanomedicines and Vaccines
Monday, November 10, 2025
4:00 PM - 4:15 PM CT
Hot Topic: The Role of AI/ML in Accelerating Development of Nanomedicines
Wednesday, November 12, 2025
3:00 PM - 4:00 PM CT
Limitations of AI/ML, Regulatory Requirements and Future Perspective
Wednesday, November 12, 2025
3:45 PM - 4:00 PM CT